Dr. Paramjit Singh Kalirao, MD

Dr. Kalirao practices at Complete Dialysis Care in Coconut Creek, Florida.

Dr. Kalirao's NPI, 1497943856, was assigned on October 11, 2007. Dr. Kalirao graduated from Ross University School of Medicine in 2004. Dr. Kalirao holds Florida license ME106249.

Dr. Kalirao's primary practice is Complete Dialysis Care, at 5300 W Hillsboro Blvd, Coconut Creek, FL 33073 in Broward County. The practice phone is (954) 753-0248.

Dr. Kalirao's primary practice is Complete Dialysis Care in Coconut Creek, Florida. Dr. Kalirao is also affiliated with Broward Health Coral Springs. The medical group on file is Florida Kidney Physicians. Dmand AI also links Dr. Kalirao to 3 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalirao practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kalirao's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kalirao is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kalirao's licenses on file in 3 states: Florida, Minnesota and New Jersey.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Kalirao treats.

CMS data shows 1,445 Medicare services from Dr. Kalirao across 12 procedure codes in 2024, for 345 Medicare patients. Medicare paid $113,014 for them.

CMS counts 345 Medicare patients who saw Dr. Kalirao in 2024. The largest group is 75 to 84, with 125 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 4.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalirao's median patient age at 73, with 47% women.

In 2024, Dr. Kalirao wrote 1,270 Medicare Part D claims for 217 patients. 80% of them were for generic drugs. CMS names the drug for 1,072 of them, across 29 drugs with 11 or more claims each, at $263,836 in total drug cost. In 2023, CMS named 1,372 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kalirao for performance year 2024, reported individually. Dr. Kalirao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalirao as offering telehealth.

Dmand AI links Dr. Kalirao to 4 clinical trials, 2 of them phase 3 studies. Conditions studied include Renal Insufficiency, Chronic, Renal Insufficiency and Kidney Diseases. GlaxoSmithKline sponsors the most, 2. Open Payments lists research payments to Dr. Kalirao that name 1 trial.

CMS Open Payments shows 257 general payments to Dr. Kalirao from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Astute Medical, Inc. paid the most, $1,598. It also lists 21 research payments totaling $4,490 from 2016 to 2019, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Kalirao, most recently CMS Stage 1 2012 in 2011.

Dr. Kalirao graduated from Ross University School of Medicine in 2004.

Dr. Kalirao is in network with 19 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.